JP Patent

JP7843116B2 — ２－（５－（４－（２－モルホリノエトキシ）フェニル）ピリジン－２－イル）－ｎ－ベンジルアセトアミドの固体形態

Assigned to エイティーエヌエックス エスピーブイ リミテッド ライアビリティ カンパニー · Expires 2026-04-09 · 0y expired

What this patent protects

Patent listed against Klisyri.

Drugs covered by this patent

Patent Metadata

Patent number
JP7843116B2
Jurisdiction
JP
Classification
—
Expires
2026-04-09
Drug substance claim
No
Drug product claim
No
Assignee
エイティーエヌエックス エスピーブイ リミテッド ライアビリティ カンパニー
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.